{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:42:27Z","timestamp":1792154547222,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["KA 4199\/1-1"],"award-info":[{"award-number":["KA 4199\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"COMBACTE-MAGNET","award":["115737-2"],"award-info":[{"award-number":["115737-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3549-0","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T09:46:52Z","timestamp":1537955212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital"],"prefix":"10.1186","volume":"18","author":[{"given":"Sabine","family":"Engler-H\u00fcsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-6160","authenticated-orcid":false,"given":"Thomas","family":"Heister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico T","family":"Mutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"3549_CR1","unstructured":"World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance. [Internet]. 2015 [cited 2018 Jun 11]. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/163468\/1\/9789241564946_eng.pdf?ua=1&ua=1"},{"issue":"02","key":"3549_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1086\/501871","volume":"22","author":"T Kim","year":"2001","unstructured":"Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol. 2001 Feb;22(02):99\u2013104.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"3549_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/cid\/cis552","volume":"55","author":"MJ Neidell","year":"2012","unstructured":"Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, et al. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55(6):807\u201315.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3549_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10198-008-0132-3","volume":"10","author":"A Resch","year":"2009","unstructured":"Resch A, Wilke M, Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ. 2009;10(3):287\u201397.","journal-title":"Eur J Health Econ"},{"key":"3549_CR5","doi-asserted-by":"crossref","unstructured":"Mutters NT, G\u00fcnther F, Sander A, Mischnik A, Frank U. Influx of multidrug-resistant organisms by country-to-country transfer of patients. BMC Infect Dis. 2015 [cited 2018 Jun 11];15(1). Available from: \n                    http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1173-8","DOI":"10.1186\/s12879-015-1173-8"},{"key":"3549_CR6","first-page":"Doc11","volume":"12","author":"F Ibert","year":"2017","unstructured":"Ibert F, Eckstein M, G\u00fcnther F, Mutters NT. The relationship between subjective perception and the psychological effects of patients in spatial isolation. GMS Hyg Infect Control. 2017;12:Doc11.","journal-title":"GMS Hyg Infect Control"},{"issue":"10","key":"3549_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/cid\/civ075","volume":"60","author":"VC Cluzet","year":"2015","unstructured":"Cluzet VC, Gerber JS, Nachamkin I, Metlay JP, Zaoutis TE, Davis MF, et al. Duration of colonization and determinants of earlier clearance of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2015;60(10):1489\u201396.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3549_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1086\/651110","volume":"50","author":"N Graves","year":"2010","unstructured":"Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care\u2013associated infections: mind your p\u2019s and q\u2019s. Clin Infect Dis. 2010;50(7):1017\u201321.","journal-title":"Clin Infect Dis"},{"key":"3549_CR9","doi-asserted-by":"crossref","unstructured":"H\u00fcbner C, Ried W, Flessa S. Assessing the opportunity costs of patients with multidrug-resistant organisms in hospitals. Eur J Health Econ. 2017 [cited 2018 Jun 11]; Available from: \n                    http:\/\/link.springer.com\/10.1007\/s10198-017-0949-8","DOI":"10.1007\/s10198-017-0949-8"},{"issue":"2","key":"3549_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhin.2016.02.013","volume":"93","author":"NT Mutters","year":"2016","unstructured":"Mutters NT, G\u00fcnther F, Frank U, Mischnik A. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures. J Hosp Infect. 2016;93(2):191\u20136.","journal-title":"J Hosp Infect"},{"issue":"3","key":"3549_CR11","first-page":"4","volume":"12","author":"W Quentin","year":"2010","unstructured":"Quentin W, Geissler A, Scheller-Kreinsen D, Busse R. DRG-type hospital payment in Germany: the G-DRG system. Euro Obs. 2010;12(3):4\u20136.","journal-title":"Euro Obs"},{"key":"3549_CR12","first-page":"Doc23","volume":"8","author":"J-P Braun","year":"2010","unstructured":"Braun J-P, Bause H, Bloos F, Geldner G, Kastrup M, Kuhlen R, et al. Peer reviewing critical care: a pragmatic approach to quality management. GMS Ger Med Sci. 2010;8:Doc23 ISSN 1612\u20133174.","journal-title":"GMS Ger Med Sci"},{"key":"3549_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijcard.2014.11.095","volume":"179","author":"A Gutmann","year":"2015","unstructured":"Gutmann A, Kaier K, Sorg S, von zur M\u00fchlen C, Siepe M, Moser M, et al. Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German health care system. Int J Cardiol. 2015;179:231\u20137.","journal-title":"Int J Cardiol"},{"issue":"4","key":"3549_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11239-012-0829-0","volume":"35","author":"J Rein\u00f6hl","year":"2013","unstructured":"Rein\u00f6hl J, Gutmann A, Kollum M, von zur M\u00fchlen C, Baumbach H, Avlar M, et al. Transfemoral aortic valve implantation: bleeding events, related costs and outcomes. J Thromb Thrombolysis. 2013;35(4):469\u201375.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"3549_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2191-1991-2-15","volume":"2","author":"M Vogl","year":"2012","unstructured":"Vogl M. Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany. Health Econ Rev. 2012;2(1):15.","journal-title":"Health Econ Rev"},{"key":"3549_CR16","doi-asserted-by":"crossref","unstructured":"Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2012;17(46).","DOI":"10.2807\/ese.17.46.20316-en"},{"issue":"5","key":"3549_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"11","key":"3549_CR18","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"issue":"4","key":"3549_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1258\/1355819042250249","volume":"9","author":"J Barber","year":"2004","unstructured":"Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9(4):197\u2013204.","journal-title":"J Health Serv Res Policy"},{"issue":"1","key":"3549_CR20","first-page":"1","volume":"1","author":"M Griswold","year":"2004","unstructured":"Griswold M. Analyzing health care costs: a comparison of statistical methods motivated by Medicare colorectal Cancer charges. Biostatistics. 2004;1(1):1\u201323.","journal-title":"Biostatistics"},{"key":"3549_CR21","doi-asserted-by":"crossref","unstructured":"Smith VA, Maciejewski ML, Olsen MK. Modeling Semicontinuous Longitudinal Expenditures: A Practical Guide. Health Serv Res. 2018 [cited 2018 Jun 11]; Available from: \n                    http:\/\/doi.wiley.com\/10.1111\/1475-6773.12815","DOI":"10.1111\/1475-6773.12815"},{"issue":"2","key":"3549_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1536867X1201200209","volume":"12","author":"R Williams","year":"2012","unstructured":"Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308.","journal-title":"Stata J"},{"issue":"1","key":"3549_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jhin.2013.06.016","volume":"85","author":"P Lloyd-Smith","year":"2013","unstructured":"Lloyd-Smith P, Younger J, Lloyd-Smith E, Green H, Leung V, Romney MG. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay. J Hosp Infect. 2013;85(1):54\u20139.","journal-title":"J Hosp Infect."},{"issue":"3","key":"3549_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11606-016-3862-4","volume":"32","author":"K Tran","year":"2017","unstructured":"Tran K, Bell C, Stall N, Tomlinson G, McGeer A, Morris A, et al. The effect of hospital isolation precautions on patient outcomes and cost of care: a multi-site, retrospective, propensity score-matched cohort study. J Gen Intern Med. 2017;32(3):262\u20138.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"3549_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/pch\/9.1.21","volume":"9","author":"J Robinson","year":"2004","unstructured":"Robinson J. Colonization and infection of the respiratory tract: what do we know? Paediatr Child Health. 2004;9(1):21\u20134.","journal-title":"Paediatr Child Health"},{"issue":"24","key":"3549_CR26","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","volume":"368","author":"SS Huang","year":"2013","unstructured":"Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368(24):2255\u201365.","journal-title":"N Engl J Med"},{"issue":"12","key":"3549_CR27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1111\/j.1469-0691.2010.03324.x","volume":"16","author":"RE Nelson","year":"2010","unstructured":"Nelson RE, Samore MH, Smith KJ, Harbarth S, Rubin MA. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect. 2010;16(12):1740\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"3549_CR28","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.ajic.2014.06.024","volume":"42","author":"E Jung","year":"2014","unstructured":"Jung E, Byun S, Lee H, Moon SY, Lee H. Vancomycin-resistant enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization. Am J Infect Control. 2014;42(10):1062\u20136.","journal-title":"Am J Infect Control"},{"issue":"2","key":"3549_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1086\/345436","volume":"36","author":"CD Salgado","year":"2003","unstructured":"Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36(2):131\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3549_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s15010-013-0410-6","volume":"41","author":"NT Mutters","year":"2013","unstructured":"Mutters NT, Frank U. Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci. Infection. 2013;41(2):305\u201310.","journal-title":"Infection"},{"issue":"9","key":"3549_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ajic.2012.11.019","volume":"41","author":"NT Mutters","year":"2013","unstructured":"Mutters NT, Brooke RJ, Frank U, Heeg K. Low risk of apparent transmission of vancomycin-resistant enterococci from bacteraemic patients to hospitalized contacts. Am J Infect Control. 2013;41(9):778\u201381.","journal-title":"Am J Infect Control"},{"issue":"5","key":"3549_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3414\/ME9241","volume":"48","author":"M Wolkewitz","year":"2009","unstructured":"Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Efficient risk set sampling when a time-dependent exposure is present. Methods Inf Med. 2009;48(5):438\u201343.","journal-title":"Methods Inf Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3549-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3549-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3549-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:03:23Z","timestamp":1569438203000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3549-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3549"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3549-0","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"17 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients provided informed written consent on admission to the use of their pseudonymized data for scientific purposes, in accordance with German data protection law. The study only included pseudonymized routine data and the researchers were unable to connect data to individual patients. The study was conducted as part of the research project \u201cTowards a full picture of the costs of antimicrobial resistance\u201d funded by the German Research Foundation (DFG KA 4199\/1\u20131). The project and its individual work packages were approved by the Ethics Committee of the University of Freiburg (Application 305\/14) covering the present study. The data used were obtained from and used with permission of the Institute for Infection Prevention and Hospital Epidemiology and the Hospital Administration Department.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable: no individual patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"737"}}